secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2025-10-20T23:59:59+00:00
Accession:  0001493152-25-018637
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.01, 5.02, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim appoints Executive Chairman, approves 1-for-18 reverse split; Nasdaq extension to Dec 31
--------------------------------------------------------------------------------

- Michael Mulica appointed Executive Chairman effective Oct 16, 2025; receives $300k salary, $250k annual RSU grant, and $500k RSU award tied to asset purchase with Social Mobile.
- Stockholders approved reverse stock split at 1-for-18 ratio, effective Oct 27, 2025, to regain compliance with Nasdaq minimum bid price.
- Stockholders also approved increase in authorized shares from 100M to 1B; did not approve 1M share increase in equity incentive plan.
- Nasdaq granted extension until Dec 31, 2025 to regain compliance with stockholders' equity minimum of $2.5M; company submitted compliance plan.
- Reverse Stock Split will not issue fractional shares; cash in lieu will be paid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/0001493152-25-018637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315225018637/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer